¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"blood group specific substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
¿µ¹® blood volume ÇÑ±Û Ç÷¾×·®
¼³¸í   
  Ã¼³»¿¡ Á¸ÀçÇϴ Ç÷¾×ÀÇ ÃÑ·®À¸·Î¼­, º¸Åë ¸®ÅÍ ¶Ç´Â Ã¼Áß 1kg¿¡ ´ëÇÏ¿© ¸®Åͼö·Î Ç¥½ÃÇÑ´Ù.
¿µ¹® blood urea nitrogen ÇÑ±Û Ç÷¾×¿ä¼ÒÁú¼Ò
¼³¸í   
  ¿ä¼Ò´Â ¾Æ¹Ì³ë»êÀÇ Å»¾Æ¹Ì³ë¿¡ ÀÇÇØ »ý±ä ¾Ï³ë´Ï¾Æ¿Í Åº»ê°¡½º·ÎºÎÅÍ °£¿¡¼­ ÇÕ¼ºµÈ´Ù. Ç÷Áß¿¡¼­´Â Ç÷Àå°ú Ç÷±¸ÀÇ ¹°¼ººÐ ¾È¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Ù. Ç÷¾×¿ä¼ÒÁú¼Ò´Â ÄáÆÏÅ丮¿¡¼­ ¿©°úµÇ¸ç ÀϺΠ¿ä¼¼°ü¿¡¼­ ÀçÈí¼öµÇ°í, ³ª¸ÓÁö°¡ ¿ÀÁÜÁß¿¡ ¹è¼³µÈ´Ù. µû¶ó¼­ Ç÷¾×¿ä¼ÒÁú¼Ò´Â ÄáÆÏ±â´ÉÀÇ ÀúÇÏ¿¡ µû¶ó Áõ°¡µÇÁö¸¸, ½Ä»ç´Ü¹éÁú ¼·Ãë·®, Á¶Á÷ºØ±«, À§Àå°ü ÃâÇ÷ µî°ú Å»¼ö µî ¼øÈ¯Ç÷¾×·®ÀÇ ÀÌ»óÀ¸·Î º¯µ¿µÈ´Ù.
¿µ¹® blood product ÇÑ±Û Ç÷¾×Á¦Á¦
¼³¸í   
  1. »ç¶÷ÀÇ Ç÷¾×À» ¼ººÐº°·Î ºÐ¸®ÇÏ¿©, ±×°ÍÀ» ¿ø·á·Î Á¦Á¶ÇÑ ÀǾàǰ. ¾Ç¼º Á¾¾ç µûÀ§¿¡ ¼öÇ÷Çϴ ÀûÇ÷±¸, ¹éÇ÷º´-ÀÚ»ö¹Ýº´ÀÇ ÃâÇ÷À» ¸Ü°ÔÇϴ Ç÷¼ÒÆÇ, È­»óÀÇ Ä¡·á¿¡ ¾²´Â Ç÷Àå, »êÈÄ ÃâÇ÷À» ¸Ü°Ô Çϴ ¼¶À¯¼Ò¿ø µûÀ§°¡ ÀÖ´Ù. 2. »ç¶÷ÀÇ Ç÷¾×ÇüÀ» °Ë»çÇϴµ¥ ¾²´Â ¾à.
¿µ¹® blood urea nitrogen(BUN) ÇÑ±Û Ç÷Áß¿ä¼ÒÁú¼Ò
¼³¸í   
  Ç÷¾×¼ÓÀÇ ¿ä¼Ò¸¦ ¸»ÇÑ´Ù. ¿ä¼Ò¶õ ´Ü¹éÁúÀ̳ª ¾Æ¹Ì³ë»êÀÇ ÃÖÁ¾»ê¹°·Î½á °£¿¡¼­ »ý»êµÇ¾î ÄáÆÏÀ¸·Î ¹èÃâµÇ´Â ¹°ÁúÀÌ´Ù. À̰ÍÀº Àΰ£¿¡°Ô ¾ø¾î¼­´Â ¾ÈµÉ ´Ü¹éÁú°ú ¾Æ¹Ì³ë»êÀÇ »ê¹°À̹ǷΠ»ç¶÷¿¡°Õ ¾ðÁ¦³ª ÀÏÁ¤·®ÀÌ »ý»êµÈ´Ù. ÄáÆÏÀÇ ±â´ÉÀÌ ³ª»Ü °æ¿ì¿¡´Â À̰ÍÀÌ ÄáÆÏÀ¸·Î ¹è¼³µÇÁö ¸øÇÏ°í ¸ö¼Ó¿¡ ÃàÀûµÈ´Ù. ±×·¯¹Ç·Î ÄáÆÏÀÇ ±â´ÉÃøÁ¤¿¡ À̰ÍÀÌ À̿렵ȴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • coliform group
    ´ëÀå±Õ±º
  • complementation group
    »óº¸¼ºÁý´Ü
  • control group
    ´ëÁ¶±º
  • determinant group
    °áÁ¤±º
  • diagnosis related group
    Æ÷°ý¼ö°¡Á¦
  • directive group therapy
    Áö½ÃÁý´Ü¿ä¹ý
  • end group
    ¸»´Ü±â
  • enteric group
    âÀÚ±Õ±º, Àå±Õ±º
  • functional group
    ÀÛ¿ë±â
  • glucophore group
    ´Ü¸À´Ü
  • group
    1. ±º, ¹«¸®, Áý´Ü 2. ±â 3. Á· 4. ±×·ì
  • group antigen
    ¹«¸®Ç׿ø, ±ºÇ׿ø
  • group audiometry
    Áý´Üû·Â°Ë»ç
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢
  • group dynamics
    Áý´Ü¿ªÇÐ, Áý´Ü¿ªµ¿
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • blood film
    Ç÷¾×Æì¹Ù¸¥Ç¥º», Ç÷¾×µµ¸»
  • blood flow
    Ç÷·ù
  • blood pressure fluctuation
    Ç÷¾Ðº¯µ¿, Ç÷¾Ð±âº¹
  • arterial blood gas
    µ¿¸ÆÇ÷°¡½º
  • blood grouping
    Ç÷¾×Çü°Ë»ç
  • blood gas
    Ç÷¾×°¡½º
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • blood coagulation mechanism
    Ç÷¾×ÀÀ°í±âÀü
  • blood urea nitrogen
    Ç÷¾×¿ä¼ÒÁú¼Ò
  • blood pressure
    Ç÷¾Ð
  • blood product
    Ç÷¾×Á¦Á¦
  • portal blood pressure
    ¹®¸Æ¾Ð
  • blood flow rate
    Ç÷·ù·®, Ç÷·ù¼Óµµ
  • arterial blood gas study
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • blood sugar
    Ç÷´ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • specific absorption rate
    ƯÀÌÈí¼öÀ²
  • specific capsular reaction
    ƯÀÌÇǸ·¹ÝÀÀ
  • specific death rate
    ƯÀÌ»ç¸Á·ü
  • specific fertility rate
    ƯÀÌÃâ»êÀ²
  • specific growth rate
    ƯÀÌÁõ½Ä·ü
  • specific marriage rate
    ƯÀ̰áÈ¥À²
  • specific morbidity rate
    ƯÀÌÀÌȯÀ²
  • specific mortality rate
    ƯÀÌ»ç¸Á·ü
  • specific reading retardation
    ƯÁ¤ÀбâÁö¿¬
  • specific
    ƯÀÌ-, ƯÁ¤-
  • specific serum
    ƯÀÌÇ÷û
  • specific gravity test
    ºñÁß½ÃÇè
  • virus-specific
    ¹ÙÀÌ·¯½ºÆ¯ÀÌ-
  • amino group
    ¾Æ¹Ì³ë±â
  • atomic group
    ¿øÀÚ´Ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • agglutinable substance
    ÀÀÁý¼º ¹°Áú(ëêó¢àõÚªòõ).
  • anterior perforated substance
    ¾Õ°üÅëÁú
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • antibacterial substance
    Ç×±Õ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú.
  • antimold (substance)
    Ç×°õÆÎÀÌ(¹°Áú).
  • antithyroid substance
    Ç×°©»ó¼±¹°Áú.
  • antiyeast substance
    Ç×È¿¸ð¹°Áú.
  • gelatinous substance
    ¾ÆaÁú, a¾çÁú(ÎïåÆòõ).
  • gelatinous substance
    ¾Æ±³Áú
  • gray substance
    ȸ»öÁú.
  • ground substance
    ±âÀú¹°Áú(Ðñî¼Úªòõ), ±âÁú(Ðñòõ).
  • heparinoid substance
    ÇìÆÄ¸°¾ç¹°Áú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • enteric group
    Àå°è¼¼±Õ±º, Àå³»¼¼±Õ±º
  • evocative group therapy
    Ç¥ÇöÀû Áý´Ü¿ä¹ý(øúúÞîÜó¢Ó¥ÖûÛö)
  • frontal group of aphasia
    ÀüµÎ¿±½Ç¾î±º(¡­ã÷åÞÏØ).
  • functional group
    ÀÛ¿ë±â(íÂéÄÐñ).
  • glucophore group
    ´ã´ç±â.
  • green or yellow vegetable group
    ³ìȲ»öä¼Ò·ù.
  • group
    ±º
  • group I fiber
    Á¦¥°±º¼¶À¯(ð¯ìéÏØàéë«).
  • group I fiber
    Á¦¥°¤Çí·A(ð¯ìéÏØàéë«).
  • group II fiber
    Á¦¥± ±º¼¶À¯(ÏØàéë«).
  • group II fiber
    Á¦¥±¤Çí·A.
  • group III fiber
    Á¦¥²±º¼¶À¯(ÏØàéë«).
  • group III fiber
    Á¦¥²¤Çí·A.
  • group IV fiber
    Á¦¥³±º¼¶À¯(ÏØàéë«).
  • group IV fiber
    Á¦¥³¤Çí·A.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇϹ°Áú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇÏÁú
  • Substance of synaptic cleft
    Æ´»õ¹°Áú
    [¿¾ ¿ë¾î] ¿­³»Áú
  • Osteoid substance
    Dz»À¹°Áú
    [¿¾ ¿ë¾î] °ñ¾çÁú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • specific interaction theory
    ƯÀÌ »óÈ£ÀÛ¿ëÀÌ·Ð(÷åì¶ßÓû»íÂéÄ×âÖå)
  • specific ionization
    ºñ(Ýï) ÀÌ¿ÂÈ­(ûù)
  • specific radioactivity
    ºñ¹æ»ç´É(ÝïÛ¯ÞÒÒö)
  • specific rate constant
    ƯÀÌ ¼Óµµ»ó¼ö(÷åì¶áÜÓøßÈâ¦)
  • specific reaction rate
    ƯÀÌ ¹ÝÀÀ¼Óµµ(÷åì¶ÚãëëáÜÓø)
  • specific refractive index increment
    ƯÀÌ ±¼ÀýÁö¼ö Áõ°¡(÷åì¶ÏÝï¹ò¦â¦ñòÊ¥)
  • specific retention volume
    ºñ Àú·ù ¿ëÀû(ÝïîÍ×µé»îÝ)
  • specific rotation
    ºñ¼±±¤µµ(ÝïàÁÎÃÓø)
  • specific rotatory power
    ºñ¼±±¤·Â(ÝïàÁÎÃÕô)
  • specific substrate concentration
    ƯÀÌ ±âÁú³óµµ(÷åì¶ÐñòõÒØÓø)
  • specific viscosity
    ºñÁ¡µµ(ÝïïÄÓø)
  • specific volumne
    ºñ¿ëÀû(Ýïé»îÝ)
  • tissue-specific enzyme
    Á¶Á÷ ƯÀÌ È¿¼Ò (ðÚòÄ÷åì¶ý£áÈ)
  • tumor-specific transplantation antigen
    Á¾¾çƯÀÌ ÀÌ½Ä Ç׿ø(ðþåË÷åì¶ì¹ãÕù÷ê«)
  • type-specific antigen
    ÇüƯÀÌ Ç׿ø(úþ÷åì¶ù÷ê«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
Gc globulin Group-specific complement globulin
GAG glycosaminoglycan; group-specific antigen gene
GC ganglion cell; gas chromatography; general circulation; general closure; general condition; generali...
Gc gigacycle; gonococcus; group-specific component
gs group specific
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
Group III group
DST Donor specific blood transfusion
BGA Blood group antigen
BGS Blood group substances
EBMT European Group for Blood and Marrow Transplantation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • specific tender point site
    ƯÁ¤ ¾ÐÅëÁ¡
  • specific weight
    ºñÁß
  • tumor specific transplantation
    Á¾¾ç ƯÀ̼º À̽Ä
  • virus-specific surface antigen
    ¹ÙÀÌ·¯½º ƯÀ̼º Ç¥¸é Ç׿ø ¹ÙÀÌ·¯½º
  • accelerans substance
    ÃËÁø¹°Áú
    ½ÉÀå ½Å°æ ÀÛ¿ëÀÇ ¾×ü Àüµµ¿¡ À־, ÃËÁø ½Å°æÀ» ÀÚ±ØÇÔÀ¸·Î½á »ý±â´Â ½É¹Ú Áõ°¡¼º À§¿îµ¿ ¾ïÁ¦¼º ¹°Áú.
  • accessory food substance
    ºÎ¿µ¾ç¹°
  • accessory growth substance
    ¹ßÀ° º¸Á¶ ¹°Áú
    ¹ßÀ°À» Çϴµ¥ º¸Á¶µÇ´Â ¹°Áú.
  • agglutinable substance
    ÀÀÁý¼º ¹°Áú
  • anti-intercellular substance antibody
    Ç×¼¼Æ÷°£ ¹°Áú Ç×ü
  • ascending substance P
    »óÇà P ¹°Áú
  • bone inducing substance
    °ñ Çü¼º À¯µµ ÀÎÀÚ
  • bone substance
    °ñÁú
  • cement substance
    Á¢ÇÕ ¹°Áú
    µÎ °³ÀÇ Ç¥¸éÀ» °ß°íÇÏ°Ô Á¢ÇÕÇÏ´Â ¹°Áú.
  • coagualtion-active substance
    ÀÀ°í Ȱ¼º ¹°Áú
  • corrosive substance
    ºÎ½Ä ¹°Áú, ºÎ½Ä¼º ¹°Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
ground substance The amorphous material in which structural elements occur; in connective tissue, it is composed of proteoglycans, plasma constituents, metabolites, water, and ions present between cells and fibres.
Synonym: substantia fundamentalis.
(05 Mar 2000)
growth substance <biology, cell biology> Signal molecules that are involved in the control of cell growth and differentiation.
(12 Dec 1998)
Rolando's gelatinous substance The apical part of the posterior horn (dorsal horn; posterior gray column) of the spinal cord's gray matter, composed largely of very small nerve cells; its gelatinous appearance is due to its very low content of myelinated nerve fibres.
Synonym: substantia gelatinosa, Rolando's gelatinous substance, Rolando's substance.
(05 Mar 2000)
chromidial substance Endoplasmic reticulum in which ribosomal granules are applied to the cytoplasmic surface of the cisternae; involved in the synthesis and secretion of protein via membrane-bound vesicles to the extracellular space.
Synonym: chromidial substance, ergastoplasm, rough-surfaced endoplasmic reticulum.
(05 Mar 2000)
chromophil substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
compact substance The compact, noncancellous portion of bone that consists largely of concentric lamellar osteons and interstitial lamellae.
Synonym: substantia compacta, compact substance, substantia compacta ossium.
(05 Mar 2000)
white substance <anatomy> Brain tissue composed of myelin-coated nerve cell fibres. White matter carries information between the nerve cells in the brain and spinal cord.
The inner portion of the cerebrum is composed of white matter.
See: grey matter.
(13 Nov 1997)
mullerian inhibiting substance A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin.
Synonym: mullerian inhibiting factor.
(05 Mar 2000)
muscular substance of prostate The smooth muscle in the stroma of the prostate.
Synonym: substantia muscularis prostatae, musculus prostaticus.
(05 Mar 2000)
controlled substance A substance subject to the Controlled Substances Act (1970), which regulates the prescribing and dispensing, as well as the manufacturing, storage, sale, or distribution of substance's assigned to five schedules according to their 1) potential for or evidence of abuse, 2) potential for psychic or physiologic dependence, 3) contributing a public health risk, 4) harmful pharmacologic effect, or 5) role as a precursor of other controlled substance's.
(05 Mar 2000)
cortical substance The superficial thin layer of compact bone.
Synonym: substantia corticalis, cortical substance.
(05 Mar 2000)
posterior perforated substance The bottom of the interpeduncular fossa at the base of the midbrain, extending from the anterior border of the pons forward to the mamillary bodies, and containing numerous openings for the passage of perforating branches of the posterior cerebral arteries.
Synonym: substantia perforata posterior, locus perforatus posticus, Malacarne's space.
(05 Mar 2000)
pressor substance One of several products of intestinal putrefaction believed to cause functional hypertension when absorbed, any alkaline substance that raises blood pressure.
Synonym: pressor amine, pressor substance.
(05 Mar 2000)
proper substance See: substantia propria of cornea, substantia propria membranae tympani, substantia propria sclerae.
(05 Mar 2000)
schwann's white substance <anatomy> The substance of the medullary sheath.
Source: Websters Dictionary
(01 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Group of 77
    77°³±¹ ±×·ì(UNÀÇ ¹«¿ª°³¹ß ȸÀÇ(UNCTAD)ÀÇ È¸¿øÀÎ ¹ßÀü µµ»ó±¹ ±×·ì)
  • Group of Seven
    G;7 ¼±Áø 7°³±¹ ±×·ì
  • code group
    ºÎÈ£±º
  • continuous group
    ¿¬¼Ó±º
  • control group
    Á¦¾îÁý´Ü;Á¶Á¾ÀåÄ¡;´ëÁ¶±º(µ¿ÀϽÇÇè¿¡¼­ ½ÇÇè¿ä°ÇÀ» °¡ÇÏÁö ¾ÊÀº ±×·ì)
  • enxounter group
    (Á¤ÀÇ)Áý´Ü °¨¼ö¼º ÈÆ·Ã ±×·ì
  • ethnic group
    (»çȸ)ÀÎÁ¾ Áý´Ü
  • focus group
    Æ÷Ä¿½º ±×·ì(Å×½ºÆ®ÇÒ »óǰ¿¡ ´ëÇØ¼­ ÅäÀÇÇÏ´Â ¼ÒºñÀÚ ±×·ì)
  • fringe group
    ºñÁÖ·ùÆÄ
  • front group
    (À§ÀåÇÑ) Ç¥¸é»óÀÇ Á¶Á÷(´Üü)
  • ginger group
    (Á¤´ç µûÀ§ Á¶Á÷ ³»ºÎÀÇ)Çõ½ÅÆÄ
  • group
    ¹«¸®;ºñÇà ´ë´ë;ºñÇà ¿¬´ë
  • group
    ¸ðÀ¸(ÀÌ)´Ù;ºÐ·ùÇÏ´Ù
  • group captain
    °ø±º ´ë·É
  • group dynamics
    Áý´Ü ¿ªÇÐ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á